Chemistaa India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 1.45%
- Profit Growth 1690.78%
- Ebitda 29.85%
- Net Worth 6.51%
- Total Assets -8.06%
About Chemistaa India
Chemistaa India Private Limited (CIPL) is a Private Limited Indian Non-Government Company incorporated in India on 26 December 2011 and has a history of 13 years and one month. Its registered office is in Sonipat, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Kalra and Chander Mohan serve as directors at the Company.
Company Details
-
Location
Sonipat, Haryana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24100HR2011PTC044676
-
Company No.
044676
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
26 Dec 2011
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Chemistaa India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kalra
|
Director | 26-Dec-2011 | Current |
|
Chander Mohan
|
Director | 26-Dec-2011 | Current |
Financial Performance of Chemistaa India.
Chemistaa India Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 1.45% increase. The company also saw a substantial improvement in profitability, with a 1690.78% increase in profit. The company's net worth moved up by a moderate rise of 6.51%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Chemistaa India?
In 2022, Chemistaa India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Bhagwan Devi Pharmaceuticals Private LimitedManoj Kalra and Chander Mohan are mutual person
-
Research Medicine Private Limited
Manoj Kalra and Chander Mohan are mutual person
-
Rescare Pharmaceuticals Private Limited
Manoj Kalra and Chander Mohan are mutual person
-
Oribelle Cosmetics Private Limited
Manoj Kalra is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Chemistaa India?
Unlock and access historical data on people associated with Chemistaa India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Chemistaa India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Chemistaa India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
